Evidence map›Paper›PMID 26227946›Full record

ReviewMolecular nutrition & food research2016

Dietary inorganic nitrate: From villain to hero in metabolic disease?

Ben McNally, Julian L Griffin, Lee D Roberts

Open access · hybridAbstract readReview
In one paragraph

Review in Molecular nutrition & food research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ben McNallyElsie Widdowson Laboratory, Medical Research Council - Human Nutrition Research, Cambridge, UK.
Julian L GriffinElsie Widdowson Laboratory, Medical Research Council - Human Nutrition Research, Cambridge, UK.
Lee D RobertsElsie Widdowson Laboratory, Medical Research Council - Human Nutrition Research, Cambridge, UK.
Medical Research Council · GB

Funding

Biotechnology and Biological Sciences Research Council Bb/H013539/2Biotechnology and Biological Sciences Research Council bb/I000933/IBritish Heart FoundationMedical Research Council MC_UP_A090_1006Medical Research Council MR/P011705/1Medical Research Council UD99999906Wellcome Trust 093148/Z/10/Z
6 · The paper itself

Abstract

Historically, inorganic nitrate was believed to be an inert by-product of nitric oxide (NO) metabolism that was readily excreted by the body. Studies utilising doses of nitrate far in excess of dietary and physiological sources reported potentially toxic and carcinogenic effects of the anion. However, nitrate is a significant component of our diets, with the majority of the anion coming from green leafy vegetables, which have been consistently shown to offer protection against obesity, type 2 diabetes and metabolic diseases. The discovery of a metabolic pathway in mammals, in which nitrate is reduced to NO, via nitrite, has warranted a re-examination of the physiological role of this small molecule. Obesity, type 2 diabetes and the metabolic syndrome are associated with a decrease in NO bioavailability. Recent research suggests that the nitrate-nitrite-NO pathway may be harnessed as a therapeutic to supplement circulating NO concentrations, with both anti-obesity and anti-diabetic effects, as well as improving vascular function. In this review, we examine the key studies that have led to the re-evaluation of the physiological function of inorganic nitrate, from toxic and carcinogenic metabolite, to a potentially important and beneficial agent in the treatment of metabolic disease.

Indexed as

DietAdipose TissueBiological AvailabilityDiabetes Mellitus, Type 2HeartHumansHypertensionInflammationMetabolic SyndromeNitratesNitric OxideNitric Oxide Synthase Type IINitritesObesityNitratesNitric OxideNitric Oxide Synthase Type IINitritesNOS2 protein, humanAdipose TissueDiabetesDietary inorganic nitrateMetabolic diseaseMetabolismNitric oxideObesity

Identifiers

PMID26227946
PMCPMC4863140
OpenAlexW1834027989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.